The program, which is now in its fifth year, is backed by AbbVie, Amgen, Johnson & Johnson, Medicines Australia, Pfizer, Roche and a range of other organisations and universities. …
Applications open for industry-backed Bridge Program
February 9, 2022 Latest NewsBioPharmaAustralian Biotech
Latest Video
New Stories
-
ACT unveils plan to repair New Zealand’s medicines gap by 2033
July 26, 2026 - - Latest News -
The 'Dispatched' Podcast - Series 5, Ep.25
July 24, 2026 - - Podcast -
Finalists named for the 2026 Patient's Choice awards
July 24, 2026 - - Latest News -
The 'end of days' language is just a farcical attempt to shut down discussion
July 24, 2026 - - Latest News -
Australian company moving headquarters to US and restructuring workforce
July 24, 2026 - - Latest News -
Faster processes could push Pharmac's options for investment backlog to 400 within two years
July 23, 2026 - - Latest News -
Bellberry and ASCEPT release checklist for 'new approach methodologies' trials
July 23, 2026 - - Latest News